The publicly funded Human Genome Project (HGP) and the private company Celera Genomics announced that they had completed their first drafts of the human genome. While Celera has sequenced 99% of the genome through its shotgun technique, HGP has accurately deciphered 85% of the human genome and expects to produce a 99.99% accurate map by 2003.
Summer Footcare "Dos and Don'ts" While summer is the time for open sandals or going barefoot, this could spell serious trouble for the 16 million people with diabetes.
Los Angeles, CA. In a Judgment entered on June 5, 2000, the Honorable Lourdes G. Baird of the United States District Court for the Central District of California declared that Advanced Bio-Technologies, Inc. is the owner of the "Kelo-cote" trademark used in connection with its patented topical gel scar management product. Advanced, based in Silverdale, Washington, is the successor in interest to the "Kelo-cote" business of the former Applied Biomaterial Technologies, Inc. (aka ABT), the developer of "Kelo-cote." In the June 5, 2000, Judgment, Judge Baird confirmed that Advanced is "the lawful owner of the mark Kelo-cote" and found that Allied Biomedical Corporation has infringed upon Advanced's rights by marketing and selling a competing scar management gel under the name "Kelocote."